Welcome to MyElanco!

The MyElanco website is intended for Veterinary professionals, SQPs / RAMAs and Professional Keepers of Animals. By continuing to MyElanco you are confirming your professional status as one of the above.

Pet owners please visit our website MyPet&I.

Skip to main content
Target OA pain with Galliprant

The most advanced oral pain relief for canine OA1,2

Vets prescribe Galliprant for daily use 68% more than traditional NSAIDs7

A flexible option for dogs diagnosed with OA in the prime of their lives!

Galliprant is the only piprant recommended as part of a multimodal approach to OA management.

  • Most dogs can be dosed once a day with a whole or half tablet
  • A simple, once-daily, chewable tablet that fits into daily routine
  • No fixed monitoring schedule required on label*. Any monitoring can be fitted around the owner and pet’s needs

Galliprant was well tolerated over 9 months in a target animal safety study at doses equivalent to 15x the target dose. No treatment was stopped or dogs removed from the study due to adverse events.4

CTA-Link-page
Dosing guide

At a glance reference to help accurate prescribing and dispensing of Galliprant tablets for dogs.

Galliprant FAQ

Frequently asked questions and top tips for prescribing Galliprant; what efficacy can I expect from it?

Like what you see?

Then share this web page on:

*as field studies were to 28 days, longer-term treatment should be considered carefully & regular monitoring undertaken by the vet. Refer to Galliprant SPC section 4.9.

  1. Pye C, et al. J Small Anim Pract. 2022;63:721–738.
  2. Kirkby Shaw K. Oral presentation. American College of Veterinary Internal Medicine Forum, 3–6 June 2015, Indianapolis IN, USA.
  3. Kirkby Shaw K, et al. Vet Med Sci. 2016;2:3–9.
  4. Rausch-Derra LC, et al. Am J Vet Res 2015;76:853–859.
  5. Pfeifer JM, et al. J Vet Emerg Crit Care. 2022;32:764–768.
  6. Rausch-Derra L, et al. J Vet Intern Med 2016;30:756–763.
  7. Elanco Data on File. Market research conducted in the UK and Europe on NSAID use by 1093 users from December 2, 2021 to January 20, 2022 by Inspired Health Inc.